-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$8.00-25.65% Downside
Avid Bioservices, Inc. Frequently Asked Questions
-
What analysts cover Avid Bioservices, Inc.?
Avid Bioservices, Inc. has been rated by research analysts at RBC Capital in the past 90 days.